Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial

Next Previous
Trial Profile

Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ipatasertib (Primary) ; Paclitaxel (Primary)
  • Indications Brain metastases; Solid tumours
  • Focus Therapeutic Use
  • Acronyms ComboMATCH

Most Recent Events

  • 30 Nov 2023 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Dec 2023 to 29 Feb 2024.
  • 01 Sep 2023 Planned initiation date (estimated date for recruitment of the first subject) changed from 2 Sep 2023 to 1 Dec 2023.
  • 13 Jul 2023 Planned initiation date (estimated date of first participant enrollment) changed from 6 Mar 2023 to 2 Sep 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top